Fundamental Analysis of APPLIED THERAPEUTICS INC(NASDAQ:APLT) stock

Fundamental Rating

APLT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. Both the profitability and financial health of APLT have multiple concerns. While showing a medium growth rate, APLT is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year APLT has reported negative net income.

In the past year APLT has reported a negative cash flow from operations.

APLT had negative earnings in each of the past 5 years.

In the past 5 years APLT always reported negative operating cash flow.

1.2 Ratios

APLT has a worse Return On Assets (-368.12%) than 95.38% of its industry peers.

		Industry Rank	Sector Rank
ROA	-368.12%
ROE	N/A
ROIC	N/A

ROA(3y)-183.57%

ROA(5y)-146.93%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

APLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

APLT has more shares outstanding than it did 1 year ago.

APLT has more shares outstanding than it did 5 years ago.

There is no outstanding debt for APLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

APLT has an Altman-Z score of -14.73. This is a bad value and indicates that APLT is not financially healthy and even has some risk of bankruptcy.

APLT has a worse Altman-Z score (-14.73) than 81.68% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-14.73

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.76 indicates that APLT may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.76, APLT is doing worse than 92.47% of the companies in the same industry.

APLT has a Quick Ratio of 0.76. This is a bad value and indicates that APLT is not financially healthy enough and could expect problems in meeting its short term obligations.

APLT has a worse Quick ratio (0.76) than 91.95% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.76
Quick Ratio	0.76

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

APLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.29%, which is quite impressive.

EPS 1Y (TTM)39.29%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-112.5%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 25.36% on average over the next years. This is a very strong growth

APLT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 67.16% yearly.

EPS Next Y46.19%

EPS Next 2Y30.6%

EPS Next 3Y25.36%

EPS Next 5YN/A

Revenue Next Year-27.58%

Revenue Next 2Y159.75%

Revenue Next 3Y116.59%

Revenue Next 5Y67.16%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

APLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APLT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as APLT's earnings are expected to grow with 25.36% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y30.6%

EPS Next 3Y25.36%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for APLT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

APPLIED THERAPEUTICS INC

NASDAQ:APLT (4/26/2024, 7:00:00 PM)

After market: 4.28 0 (0%)

4.28

+0.05 (+1.18%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap453.21M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-368.12%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.38

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.76
Quick Ratio	0.76
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)39.29%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y46.19%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

APPLIED THERAPEUTICS INC (APLT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens